Move to topTop

TOKYO, JAPAN – April 1, 2025 – Terumo Corporation (TSE: 4543) today announced the establishment of "Our Promise," the long-term direction to be pursued by the entire Terumo Group to realize its Group Mission of Contributing to Society through Healthcare.

“Our Promise” represents the Group's unwavering commitment to patients. By sharing the desire to help improve patients’ lives, which is embodied in ”Our Promise,” across the group, Terumo will pursue innovative solutions that advance patient care, paving the way for a better future for both healthcare and patients.

“Throughout our 100-year history, Terumo has always cared about patients and strived to provide them with better healthcare. I firmly believe that reaffirming “Our Promise,” Terumo's unwavering commitment to patients, will drive our growth and help us further manifest our Group Mission,” said Hikaru Samejima, Chief Executive Officer, Terumo Corporation.  

Our Promise

Everything starts from our unwavering commitment to patients. 
Listening sincerely to their needs and understanding deeply their hopes and aspirations, we boldly pursue innovative ways to help enhance the lives of patients around the world.

 

<Our Promise story>
Terumo was founded by a group of physicians and scientists to support the lives of people. Ever since then, we have been doing all we can to advance healthcare and enhance patients’ quality of life. 
This mindset, expressed in our Group Mission “Contributing to Society through Healthcare“ drives our continuous transformation to do even more.

We will listen sincerely to patients’ needs and deepen our understanding of their hopes and aspirations to discover what will be truly beneficial for them. We will work more closely with healthcare professionals and partners pursuing innovative solutions and ways to advance patient care together. And we will continue to expand our activities and take on new challenges with the thoughts and feelings of patients in mind.

We are driven by our desire to help improve patients’ lives. By putting this unwavering commitment into action, we will realize a better future for healthcare and patients.

Group brand video and visuals

Terumo also launched a video and visuals that express the Group's unwavering commitment to improving patients’ lives, which is embodied in “Our Promise.”


(Reference) Group brand video and visuals


Brand video

 

Brand visuals
 
 
 
 
 

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

 

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.